Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Free Cash Flow Yield on January 27, 2025: -4.09%

Shanghai Haoyuan Chemexpress Co., Ltd. Free Cash Flow Yield is -4.09% on January 27, 2025, a 28.53% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Shanghai Haoyuan Chemexpress Co., Ltd. 52-week high Free Cash Flow Yield is -3.35% on November 11, 2024, which is 18.23% above the current Free Cash Flow Yield.
Shanghai Haoyuan Chemexpress Co., Ltd. 52-week low Free Cash Flow Yield is -12.06% on July 04, 2024, which is -194.70% below the current Free Cash Flow Yield.
Shanghai Haoyuan Chemexpress Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is -6.50%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years